Holen Sie sich die Stockscreener-App
616.44
0.65%
-4.04
Handel nachbörslich:
616.44
Schlusskurs vom Vortag:
$620.48
Offen:
$616.99
24-Stunden-Volumen:
207.41K
Relative Volume:
0.71
Marktkapitalisierung:
$17.21B
Einnahmen:
$2.68B
Nettoeinkommen (Verlust:
$460.40M
KGV:
38.78
EPS:
15.8963
Netto-Cashflow:
$711.00M
1W Leistung:
+5.14%
1M Leistung:
+6.56%
6M Leistung:
+35.89%
1J Leistung:
+25.61%
1-Tages-Spanne:
$612.53
$625.01
1-Wochen-Bereich:
$577.64
$625.01
52-Wochen-Spanne:
$373.00
$677.90
Medpace Holdings Inc Stock (MEDP) Company Profile
Firmenname
Medpace Holdings Inc
Sektor
Branche
Telefon
(513) 579-9911
Adresse
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP vs TMO, DHR, NTRA, IQV, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MEDP
Medpace Holdings Inc
|
616.44 | 16.40B | 2.68B | 460.40M | 711.00M | 15.90 |
TMO
Thermo Fisher Scientific Inc
|
648.43 | 225.48B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
208.36 | 140.70B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
345.34 | 47.41B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
268.82 | 43.09B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
153.69 | 41.42B | 7.23B | 1.41B | 1.09B | 4.979 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2026-03-03 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-02-18 | Hochstufung | TD Cowen | Sell → Hold |
| 2026-02-13 | Hochstufung | Jefferies | Hold → Buy |
| 2026-02-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-02 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-09-03 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-29 | Herabstufung | UBS | Neutral → Sell |
| 2025-07-23 | Herabstufung | TD Cowen | Hold → Sell |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-04-22 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-03-24 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-10-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-27 | Herabstufung | UBS | Buy → Neutral |
| 2024-09-25 | Herabstufung | Jefferies | Buy → Hold |
| 2024-08-01 | Eingeleitet | Truist | Hold |
| 2024-05-29 | Eingeleitet | TD Cowen | Buy |
| 2024-05-28 | Eingeleitet | Mizuho | Buy |
| 2024-04-23 | Hochstufung | Jefferies | Hold → Buy |
| 2024-03-18 | Eingeleitet | Deutsche Bank | Hold |
| 2024-02-15 | Hochstufung | UBS | Neutral → Buy |
| 2023-10-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-05-08 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-10-27 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-07 | Eingeleitet | UBS | Sell |
| 2022-05-24 | Eingeleitet | Guggenheim | Neutral |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-10-02 | Hochstufung | Truist | Hold → Buy |
| 2020-06-08 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2020-05-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-04-30 | Hochstufung | SunTrust | Sell → Hold |
| 2020-04-20 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-03-17 | Herabstufung | SunTrust | Hold → Sell |
| 2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
| 2018-10-31 | Hochstufung | SunTrust | Hold → Buy |
| 2018-09-17 | Eingeleitet | SunTrust | Hold |
| 2018-07-31 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-11-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2017-09-29 | Eingeleitet | Raymond James | Mkt Perform |
| 2017-07-10 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
Alle ansehen
Medpace Holdings Inc Aktie (MEDP) Neueste Nachrichten
Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 5 Years - Benzinga
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Medpace Holdings, Inc. (MEDP) And Encourages Shareholders to Reach Out - ACCESS Newswire
Medpace Holdings, Inc. (MEDP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Medpace Holdings, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsMEDP - Eastern Progress
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After President Allegedly Oversaw Misleading Disclosures: Levi & Korsinsky - Eastern Progress
Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Eastern Progress
Medpace Deadline: MEDP Investors with Losses in Excess of $100K Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit - Eastern Progress
Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Encourages Medpace Holdings, Inc. (MEDP) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Medpace Holdings Inc. (MEDP) Key Financial Ratios – Valuation, Profitability & More - Value Research
Medpace Holdings, Inc. (MEDP), Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Medpace Holdings, Inc. (MEDP), Investigation: Bronstein, Gewirtz - The National Law Review
President & CEO Of Medpace Holdings Makes $403K Sale - benzinga.com
Why Medpace (MEDP) is a Top Growth Stock for the Long-Term - Eastern Progress
Medpace Holdings Inc. (MEDP) Peer Comparison – Compare with Others - valueresearchonline.com
Medpace Holdings Insider Sold Shares Worth $403,176, According to a Recent SEC Filing - marketscreener.com
Medpace Holdings (MEDP) CEO sells 650 shares near $620 - Stock Titan
Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating Its Robust Revenue Growth and Market Position - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Medpace Holdings (MEDP) director exercises options, sells 3,858 shares - Stock Titan
President & CEO At Medpace Holdings Sells $2.90M Of Stock - Benzinga
Medpace (MEDP) CEO sells 4,673 shares near $620 in open-market trades - Stock Titan
Medpace (MEDP): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Medpace (NASDAQ: MEDP) director plans 3,858-share sale after option exercise - Stock Titan
What Investors Should Know About Medpace CEO Troendle Selling $10 Million in Stock - The Globe and Mail
Medpace (NASDAQ: MEDP) insider sells 15,978 shares in August trades - Stock Titan
Medpace (MEDP) CFO exercises options, sells 3,400 shares - Stock Titan
Don't Ignore The Insider Selling In Medpace Holdings - webull.com
Medpace (MEDP) Director Brian Carley Sells 5,000 Shares - GuruFocus
Medpace (NASDAQ:MEDP) Director Sells $4,414,590.45 in Stock - MarketBeat
Brian Carley Sells 5,000 Shares of Medpace (NASDAQ:MEDP) Stock - MarketBeat
Medpace (NASDAQ:MEDP) CEO August Troendle Sells 15,609 Shares of Stock - MarketBeat
August Troendle Sells 27,174 Shares of Medpace (NASDAQ:MEDP) Stock - MarketBeat
Medpace Holdings CEO August J. Troendle Executes Two-Day Stock Sale - Kalkine Media
Medpace Holdings (MEDP) CEO sells shares in $601–$626 trades - Stock Titan
Medpace (NASDAQ: MEDP) director sells 5,000 shares outside plan - Stock Titan
Medpace (MEDP) director sells 7,283 shares after option exercise - Stock Titan
Why Is Medpace (MEDP) Up 1.1% Since Last Earnings Report? - Yahoo Finance
Analyst recommendations: Equifax, Medpace Holdings, Applied Materials, PayPal, Moderna… - marketscreener.com
BlackRock Inc. Acquires Shares of 2,498,248 Medpace Holdings, Inc. $MEDP - MarketBeat
Medpace (NASDAQ: MEDP) officer to sell 3,400 shares of stock - Stock Titan
Madison Asset Management LLC Invests $128.96 Million in Medpace Holdings, Inc. $MEDP - MarketBeat
NewEdge Wealth LLC Invests $27.51 Million in Medpace Holdings, Inc. $MEDP - MarketBeat
Meeder Advisory Services Inc. Invests $998,000 in Medpace Holdings, Inc. $MEDP - MarketBeat
Abacus FCF Advisors LLC Invests $6.63 Million in Medpace Holdings, Inc. $MEDP - MarketBeat
Medpace Holdings Inc (MEDP) Stock Up 3.0% but GF Value Says Over - GuruFocus
Medpace (NASDAQ: MEDP) director plans $3.0M stock sale - Stock Titan
Medpace (NASDAQ: MEDP) director lines up 7,283-share Rule 144 sale - Stock Titan
Oxbow Advisors LLC Purchases New Stake in Medpace Holdings, Inc. $MEDP - MarketBeat
Pallas Capital Advisors LLC Invests $1.13 Million in Medpace Holdings, Inc. $MEDP - MarketBeat
Summit Creek Advisors LLC Invests $3.42 Million in Medpace Holdings, Inc. $MEDP - MarketBeat
Finanzdaten der Medpace Holdings Inc-Aktie (MEDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Medpace Holdings Inc-Aktie (MEDP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kraft Robert O. | Director |
Aug 26 '26 |
Option Exercise |
84.36 |
3,858 |
325,461 |
4,813 |
| Kraft Robert O. | Director |
Aug 26 '26 |
Sale |
617.81 |
3,858 |
2,383,511 |
955 |
| Troendle August J. | President & CEO |
Aug 26 '26 |
Sale |
620.03 |
4,000 |
2,480,120 |
540,544 |
| Troendle August J. | President & CEO |
Aug 25 '26 |
Sale |
620.38 |
673 |
417,516 |
544,544 |
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):